Certara Appoints Dr. Carol Gallagher as New Independent Board Member

Dr. Gallagher brings more than 30 years of drug development and commercial leadership experience to her new role PRINCETON, N.J.—June 14, 2021.  Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors.  Dr. Gallagher is an experienced biopharmaceutical director and operator and serves as a venture … Continued

1 of 1
Back to top
Powered by Translations.com GlobalLink OneLink Software